UBS Announces Two New Market Directors in San Francisco

Michael Bonomo joins as Senior Market Director and Taylor Wan joins as Market Director, reporting to Market Executive Emily de la Reguera

UBS today announced that Michael Bonomo has joined the firm as Senior Market Director and Taylor Wan has joined as Market Director in the San Francisco Market. Both will report to Emily de la Reguera , Market Executive for the San Francisco Market.

In their new roles, Michael will be responsible for leading and growing UBS's Private Wealth Management business across the San Francisco market. Taylor will oversee UBS's East Bay offices, including Walnut Creek, Danville and Incline Village, with a focus on business growth, advisor development and delivering an exceptional client experience.

"We are thrilled to welcome Mike and Taylor to UBS," said Emily de la Reguera. "Both bring deep leadership experience, strong knowledge of the local landscape, and a demonstrated commitment to supporting advisors and delivering an exceptional client experience. These additions further strengthen our leadership team and our ability to serve clients across the Bay Area."

Michael joins UBS from Morgan Stanley, where he most recently helped lead the San Francisco and Seattle Private Wealth Management markets. Earlier in his career, he served as an Associate Complex Manager in Morgan Stanley's Midtown Manhattan complex, one of the firm's largest, before being promoted to lead the Dallas Park Cities Complex. He began his career as a Financial Advisor and later moved into a producing sales manager role at Merrill Lynch.

Michael grew up in Missouri and earned his undergraduate degree from the University of Missouri–Kansas City. He also holds an MBA from Olin Business School at Washington University in St. Louis.

Taylor joins UBS from Wells Fargo Advisors, where he served as Complex Manager for the East Bay, working closely with Financial Advisors and Client Associates serving affluent and high-net-worth individuals and families. He brings more than 20 years of experience in financial services and has held leadership roles at Charles Schwab, J.P. Morgan and Wells Fargo. Across his career, he has worked with advisors across bank-based, wirehouse, independent and RIA platforms.

Taylor holds the CERTIFIED FINANCIAL PLANNERâ„¢ designation. He grew up in Texas and has called the Bay Area home for the past 13 years.

Notes to Editors

About UBS
UBS is a leading and truly global wealth manager and the leading universal bank in Switzerland. It also provides diversified asset management solutions and focused investment banking capabilities. UBS manages 7 trillion dollars of invested assets as per the fourth quarter 2025. UBS helps clients achieve their financial goals through personalized advice, solutions and products. Headquartered in Zurich, Switzerland, the firm is operating in more than 50 markets around the globe. UBS Group shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

© UBS 2026. All rights reserved. The key symbol and UBS are among the registered and unregistered trademarks of UBS. For press use only.

Media:
Christina Aquilina
Christina.aquilina@ubs.com

https://www.ubs.com

News Provided by Business Wire via QuoteMedia

UBS
The Conversation (0)
GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

More People Than Ever Taking GLP-1 Drugs for Weight Loss Growing List of Diseases Now Indicated as Treatable With GLP-1 Drugs KELOWNA, BC / ACCESS Newswire / June 17, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms,... Keep Reading...
GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand

GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand

(TheNewswire) More people than ever taking GLP-1 drugs for weight loss Growing list of diseases now indicated as treatable with GLP-1 drugs Kelowna, British Columbia TheNewswire - June 17, 2026 Lexaria Bioscience Corp. (Nasdaq: LEXX) (the "Company" or "Lexaria"), a global innovator in drug... Keep Reading...
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

600,000 New Wegovy® Pill Prescriptions Written in First Two Months KELOWNA, BC / ACCESS Newswire / April 21, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this update of additional recent developments in the... Keep Reading...
Cartier Resources Grants Stock Options

Cartier Resources Grants Stock Options

Cartier Resources Inc. (TSX-V: ECR) (the " Company ") announces that the Board of Directors granted, on December 16, 2025, a total of 3,600,000 stock options to directors and officers and to one employee of the Company. Pursuant to the terms of the Company's stock option plan, each option... Keep Reading...
AmeriTrust Announces Results of Annual General and Special Meeting

AmeriTrust Announces Results of Annual General and Special Meeting

AmeriTrust Financial Technologies Inc. (TSXV: AMT,OTC:AMTFF) (OTCQB: AMTFF) (FSE: 1ZV) ("AmeriTrust" or the "Company"), a fintech platform targeting automotive finance and specializing in used vehicle lease originations for the automotive industry, is pleased to announce the results of voting at... Keep Reading...
Canadian Investment Regulatory Organization Trade Resumption - AMT

Canadian Investment Regulatory Organization Trade Resumption - AMT

Trading resumes in: Company: AmeriTrust Financial Technologies Inc.TSX-Venture Symbol: AMTAll Issues: YesResumption (ET): 8:15 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair... Keep Reading...
AmeriTrust Announces it is Unaware of Any Material Change

AmeriTrust Announces it is Unaware of Any Material Change

TORONTO, ON / ACCESS Newswire / June 11, 2026 / AmeriTrust Financial Technologies Inc. (TSXV:AMT,OTC:AMTFF)(OTCQB:AMTFF)(Frankfurt:1ZVA) ("AmeriTrust", "AMT" or the "Company"), at the request of CIRO, wishes to confirm that the Company's management is unaware of any material change in the... Keep Reading...
AmeriTrust Announces First Quarter 2026 Financial Results

AmeriTrust Announces First Quarter 2026 Financial Results

TORONTO, ON / ACCESS Newswire / May 27, 2026 / AmeriTrust Financial Technologies Inc. (TSXV:AMT,OTC:AMTFF)(OTCQB:AMTFF)(Frankfurt:1ZVA) ("AmeriTrust", "AMT" or the "Company"), a fintech platform focused on automotive finance, announces that it has filed its interim Consolidated Financial... Keep Reading...
Steven Boms

From Skepticism to Action: Steve Boms on Canada’s Open Banking Turning Point

Canada is shaping its financial future through open banking.Steve Boms, executive director of FDATA North America, made a recent appearance on the Investing News Network podcast, where he detailed Canada’s long-awaited transition toward consumer-driven banking and how placing the Bank of Canada... Keep Reading...
AmeriTrust Announces 2025 Annual Financial Results

AmeriTrust Announces 2025 Annual Financial Results

TORONTO, ON / ACCESS Newswire / April 22, 2026 / AmeriTrust Financial Technologies Inc. (TSXV:AMT,OTC:AMTFF)(OTCQB:AMTFF)(Frankfurt:1ZVA) ("AmeriTrust", "AMT" or the "Company"), a fintech platform targeting automotive finance, is announcing that it has filed its audited Consolidated Financial... Keep Reading...

Interactive Chart

Latest Press Releases

Related News